FEIBA 500U Israel - English - Ministry of Health

feiba 500u

takeda israel ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for injection/infusion - factor viii inhibitor bypassing fraction 500 u/vial - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - control of bleeding episodes in haemophilia a patients with factor viii inhibitors and also in patients with acquired factor viii inhibitors.control of bleeding in hemophilia b patients with inhibitors, if no other specific treatment is available.

FEIBA 1000U Israel - English - Ministry of Health

feiba 1000u

takeda israel ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for injection/infusion - factor viii inhibitor bypassing fraction 1000 u/vial - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - control of bleeding episodes in haemophilia a patients with factor viii inhibitors and also in patients with acquired factor viii inhibitors .control of bleeding in hemophilia b patients with inhibitors, if no other specific treatment is available.

FEIBA 100 U/ml powder and solvent for solution for infusion (500 U/5 ml) Malta - English - Medicines Authority

feiba 100 u/ml powder and solvent for solution for infusion (500 u/5 ml)

baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - powder and solvent for solution for infusion - factor viii inhibitor bypassing fraction 100 u/ml - antihemorrhagics

FEIBA 100 U/ml powder and solvent for solution for infusion (1000 U/10 ml) Malta - English - Medicines Authority

feiba 100 u/ml powder and solvent for solution for infusion (1000 u/10 ml)

baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - powder and solvent for solution for infusion - factor viii inhibitor bypassing fraction 100 u/ml - antihemorrhagics

Medicinal Product Name : FEIBA 100 U/ml powder and solvent for solution for infusion (2500 U/25 ml) Malta - English - Medicines Authority

medicinal product name : feiba 100 u/ml powder and solvent for solution for infusion (2500 u/25 ml)

baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - powder and solvent for solution for infusion - factor viii inhibitor bypassing fraction 100 u/ml - antihemorrhagics

FEIBA 25 U/ml powder and solvent for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

feiba 25 u/ml powder and solvent for solution for infusion

baxalta innovations gmbh - feiba - powder and solvent for solution for infusion - 25 unit(s)/millilitre - blood coagulation factors; factor viii inhibitor bypassing activity - coagulation factors - it is used for: treatment of bleeding in hemophilia a patients with inhibitors; treatment of bleeding in hemophilia b patients with inhibitors, if no other specific treatment is available (see section 5.1); treatment of bleeding in non-hemophiliacs with acquired inhibitors to factor viii; prophylaxis of bleeding in hemophilia a patients with inhibitors who have experienced a significant bleed or are at high risk of significant bleeding

FEIBA 50 U/ml powder and solvent for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

feiba 50 u/ml powder and solvent for solution for infusion

baxalta innovations gmbh - feiba - powder and solvent for solution for infusion - 50 unit(s)/millilitre - blood coagulation factors; factor viii inhibitor bypassing activity - blood coagulation factors - it is used for: treatment of bleeding in hemophilia a patients with inhibitors; treatment of bleeding in hemophilia b patients with inhibitors, if no other specific treatment is available (see section 5.1); treatment of bleeding in non-hemophiliacs with acquired inhibitors to factor viii; prophylaxis of bleeding in hemophilia a patients with inhibitors who have experienced a significant bleed or are at high risk of significant bleeding

FANHDI 100 IUML 1500 IU (FACTOR VIII) Israel - English - Ministry of Health

fanhdi 100 iuml 1500 iu (factor viii)

medici medical ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1500 iu/dose - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - is indicated for the prevention and control of bleeding in patients with moderate or severe factor viii deficiency due to classical hemophilia a . fanhdi is not effective in controlling the bleeding of patients with von willebrond's disease.

Feiba 500 U, powder and solvent for solution for injection. Factor VIII Inhibitor Bypassing Activity. Malta - English - Medicines Authority

feiba 500 u, powder and solvent for solution for injection. factor viii inhibitor bypassing activity.

baxter healthcare limited - factor viii inhibitor bypassing fraction 500 u - powder and solvent for solution for injection

FEIBA VH IMMUNO ANTI INHIBITOR POWDER FOR SOLUTION Canada - English - Health Canada

feiba vh immuno anti inhibitor powder for solution

osterreichisches institut fur haemoderivate ges m.b.h. - coagulation factor x (human); coagulation factor vii (human); antihemophilic factor (human); factor ix complex human; coagulation factor ii (human) - powder for solution - nil; nil; 4unit; nil; nil - coagulation factor x (human) nil; coagulation factor vii (human) nil; antihemophilic factor (human) 4unit; factor ix complex human nil; coagulation factor ii (human) nil - hemostatics